NPI registry status
Active
2026 NPPES data Family Medicine Physician NPI 1649452301 MD
Verify on CMS → Salah Al-Abbadi, MD
Family Medicine Physician in Grove Hill, Alabama.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 147,760 in Family Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
15K
Medicare Part D claims · 569 beneficiaries · Family Medicine Physician avg: 3K
Generic prescribing
86%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$259.67
7 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Salah Al-Abbadi, MD filed 14,522 Medicare Part D claims in 2023 as a Family Medicine Physician in Grove Hill, Alabama, prescribing 86% generic.
- 15K
- Part D claims, 2023
- 86%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Salah Al-Abbadi, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
14,522 Top 2% higher than 98% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Salah Al-Abbadi, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 4 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Salah Al-Abbadi, MD?
Quality data not reportedPrimary specialty
Family Medicine Physician
Medicare Part D claims
14,522 325% vs specialty avg
Specialty distribution in Alabama
How Family Medicine Physician compares to other specialties among Alabama providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Family Medicine Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Salah Al-Abbadi, MD appears in the CMS NPPES registry as a Family Medicine Physician provider holding MD credentials at 295B S JACKSON ST, Grove Hill, AL, 36451, with a listed phone of (251) 275-3173. NPI 1649452301 was issued on 12/04/2007.
Medicare Part D records for calendar year 2023 show 14,522 prescription claims written by this provider, covering 569 Medicare beneficiaries and totaling roughly $1.6 million in drug spend, split 13% brand-name and 86% generic by claim count, with an opioid prescribing rate of 9.7%.
Family Medicine Physician is a high-volume specialty nationwide, with 147,760 enrolled providers across 56 states and an average of 3,418 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1649452301 |
|---|---|
| Specialty | Family Medicine Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 12/04/2007 |
Hospital and facility affiliations
Facilities where Salah Al-Abbadi, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
According to CMS billing records, Salah Al-Abbadi, MD is affiliated with 4 Medicare-billing facilities.
Correct Care, Inc.
Chatom, AL
Grove Hill Memorial Hospital, Inc
Grove Hill, AL
Ihp AL ER PLLC
Grove Hill, AL
Newgen Alabama Billing LLC
Grove Hill, AL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Salah Al-Abbadi, MD. Source: openpaymentsdata.cms.gov.
Total received
$260
Largest payer
Otsuka America Pharmaceutical, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Salah Al-Abbadi, MD - brand share 13.0%
Family Medicine Physician average
13% brand-name claims vs 86% generic, on 14,522 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
14,522
Total Claims
$1.6M
Total Drug Cost
569
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 23,289
- Total Day Supply
- 633,562
- Brand vs Generic
- 13% brand / 86% generic
- Brand Drug Cost
- $1.3M
- Generic Drug Cost
- $278K
- Opioid Claims
- 1,413 (9.7% rate)
- Antibiotic Claims
- 511
Patient Demographics
- Average Patient Age
- 68.5 years
- Avg HCC Risk Score
- 1.63
- Gender Split
- 61% female / 39% male
- Age Distribution
- <65: 170, 65-74: 216, 75-84: 122, 85+: 61
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Salah Al-Abbadi, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
616 claims
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
575 claims
- Amlodipine Besylate
Amlodipine Besylate
513 claims
- Gabapentin
Gabapentin
402 claims
- Oxycodone-Acetamin…
Oxycodone-Acetaminophen
337 claims
- Furosemide
Furosemide
314 claims
- Omeprazole
Omeprazole
283 claims
- Losartan Potassium
Losartan Potassium
280 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 616 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 575 |
| Amlodipine Besylate | 513 |
| Gabapentin | 402 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 337 |
| Furosemide | 314 |
| Omeprazole | 283 |
| Losartan Potassium | 280 |
| Metformin Hcl | 279 |
| Levothyroxine Sodium | 275 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Family Medicine Physician Overview
How Salah Al-Abbadi, MD fits within the Family Medicine Physician landscape nationally.
147,760
Family Medicine Physician Providers in US
56
States with Family Medicine Physician
3,418
Avg Claims per Provider
Salah Al-Abbadi, MD's 14,522 claims are above the specialty average of 3,418.
Nearby Family Medicine Physician Providers in Alabama
Other clinicians with the same primary specialty enrolled in Alabama, drawn from the same CMS NPPES roster as Al-Abbadi.
Dr. Bahaa Abdelqader
DO
Mobile, AL
Dr. Sumayah Abed
MD
Hoover, AL
Dr. Charles Abney
M.D.
Tuscaloosa, AL
Dr. Jennifer Abt
DO
Montgomery, AL
Dr. Dakota Acton Jones
M.D.
Fayette, AL
Compare Family Medicine Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Alabama medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Family Medicine Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Alabama
Frequently Asked Questions
What is Salah Al-Abbadi, MD's specialty? ▼
Salah Al-Abbadi, MD specializes in Family Medicine Physician and practices in Grove Hill, Alabama. Credentials: MD.
How much does Salah Al-Abbadi, MD prescribe under Medicare Part D? ▼
In 2023, Salah Al-Abbadi, MD wrote 14,522 Medicare Part D claims totaling $1.6M in drug costs for 569 beneficiaries.
Where is Salah Al-Abbadi, MD located? ▼
Salah Al-Abbadi, MD is located at 295B S JACKSON ST, Grove Hill, AL, 36451. Phone: (251) 275-3173.
What is Salah Al-Abbadi, MD's NPI number? ▼
Salah Al-Abbadi, MD's National Provider Identifier (NPI) is 1649452301, issued on 12/04/2007.
Does Salah Al-Abbadi, MD prescribe more brand-name or generic drugs? ▼
Salah Al-Abbadi, MD's prescribing is 13% brand-name and 86% generic drugs by claim count, with $1.3M in brand drug costs.
Does Salah Al-Abbadi, MD prescribe opioids? ▼
Yes, Salah Al-Abbadi, MD had 1,413 opioid claims in 2023 with an opioid prescribing rate of 9.7%.
How many Family Medicine Physician providers are there in the US? ▼
There are 147,760 Family Medicine Physician providers across 56 states in the US. The average Family Medicine Physician provider writes 3,418 Medicare Part D claims per year.
What drugs does Salah Al-Abbadi, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Salah Al-Abbadi, MD's most frequently prescribed drugs include Atorvastatin Calcium, Hydrocodone-Acetaminophen, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Salah Al-Abbadi, MD accept Medicare? ▼
Salah Al-Abbadi, MD appears in CMS Medicare data with 14,522 Part D claims and 569 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Salah Al-Abbadi, MD's credentials? ▼
Salah Al-Abbadi, MD's NPI is 1649452301 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.